精神分裂症患者及母体免疫激活子代小鼠中脑免疫相关转录本升高
该研究量化了精神分裂症患者与匹配对照中脑多巴胺能区域的炎症标志物,并在母体免疫激活(MIA)小鼠模型中验证。发现患者SERPINA3、TNFα、IL1β、IL6、IL6ST转录本升高(p<0.02-0.001),约45%(13/28)高免疫亚组驱动;MIA子代小鼠同样升高(p≤0.01),约40%(13/32)高免疫亚组驱动;小胶质细胞/星形胶质细胞密度形态标志无差异,但高炎症亚组胶质标志转录增加。
要点
- 精神分裂症患者中脑多巴胺能区免疫相关转录本升高,约45%病例呈高免疫状态。
- MIA子代小鼠中脑同样出现免疫标志物升高,约40%子代呈高免疫状态。
- 胶质细胞密度形态无组间差异,但高免疫亚组胶质标志转录增加。
核心结论
- 精神分裂症中脑多巴胺能区的免疫相关改变存在于小胶质细胞数量无变化的情况下,高免疫亚组可能伴小胶质细胞和星形胶质细胞激活。
- MIA可能是精神分裂症患者中脑持续神经免疫改变的 contributing factor 之一。
研究设计与样本
- 研究量化了精神分裂症患者与匹配对照中脑多巴胺能区域的炎症标志物,并检测了孕期暴露MIA的小鼠中脑。
- 人队列中高免疫亚组约占45%(13/28),小鼠MIA子代高免疫亚组约占40%(13/32)。
主要发现
- 精神分裂症患者中脑SERPINA3、TNFα、IL1β、IL6、IL6ST转录本较对照升高(p<0.02-0.001)。
- 成人MIA子代中脑SERPINA3、TNFα、IL1β mRNA表达升高(均p≤0.01)。
- 人队列和小鼠队列中小胶质细胞或星形胶质细胞密度和/或形态的细胞标志均无诊断或组间差异。
- 高炎症亚组的精神分裂症病例和MIA子代中小胶质细胞和星形胶质细胞标志转录增加。
关键数值与推荐
- 人队列中免疫标志物诊断差异由高免疫状态亚组(约45%,13/28)解释。
- 小鼠MIA子代免疫标志物升高由高免疫状态亚组(约40%,13/32)驱动。
临床怎么用
- 提示精神分裂症中脑多巴胺能区存在免疫相关转录改变,且部分病例呈高免疫状态,或可考虑免疫亚型评估。
- MIA模型支持母体免疫激活作为精神分裂症中脑持续神经免疫改变的潜在贡献因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of midbrain dopamine neurons, midbrain inflammation may play a role in schizophrenia by contributing to presynaptic dopamine abnormalities. Thus, we quantified inflammatory markers in dopaminergic areas of the midbrain of people with schizophrenia and matched controls. We also measured these markers in midbrain of mice exposed to maternal immune activation (MIA) during pregnancy, an established risk factor for schizophrenia and other psychiatric disorders. We found diagnostic increases in SERPINA3, TNFα, IL1β, IL6, and IL6ST transcripts in schizophrenia compared with controls (p < 0.02-0.001). The diagnostic differences in these immune markers were accounted for by a subgroup of schizophrenia cases (~ 45%, 13/28) showing high immune status. Consistent with the human cohort, we identified increased expression of immune markers in the midbrain of adult MIA offspring (SERPINA3, TNFα, and IL1β mRNAs, all p ≤ 0.01), which was driven by a subset of MIA offspring (~ 40%, 13/32) with high immune status. There were no diagnostic (human cohort) or group-wise (mouse cohort) differences in cellular markers indexing the density and/or morphology of microglia or astrocytes, but an increase in the transcription of microglial and astrocytic markers in schizophrenia cases and MIA offspring with high inflammation. These data demonstrate that immune-related changes in schizophrenia extend to dopaminergic areas of the midbrain and exist in the absence of changes in microglial cell number, but with putative evidence of microglial and astrocytic activation in the high immune subgroup. MIA may be one of the contributing factors underlying persistent neuroimmune changes in the midbrain of people with schizophrenia.
引用
- Purves-Tyson TD, Weber-Stadlbauer U, Richetto J, et al. Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation. Mol Psychiatry. 2019. PMID: 31168068. doi:10.1038/s41380-019-0434-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。